Oxford BioMedica Plc

Oxford BioMedica Plc

Immunotherapy development

On the 12th of March 2007 Oxford BioMedica Plc (LSE: OXB) acquired Oxxon Therapeutics, a privately held biotechnology company, in an all-share deal valued at £16 million.